Key facts

Financial results (Full-year 2020)

Product Sales

Change at constant exchange rates

Core Earnings per Share

Change at constant exchange rates



SEC filings

SEC filings are those documents that we are required to file by virtue of our listing on Nasdaq. They contain mainly financial information.

These documents are also available for viewing on the SEC website at www.sec.gov. The Company will send any holder of the Company’s securities, upon request, a hard copy of the Company’s complete audited financial statements free of charge. Requests may be made by writing to:

Company Secretary
AstraZeneca PLC
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA


Our pipeline

Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.

166

projects in our pipeline

12

new molecular entities in our late-stage pipeline

2

new molecular entity new to phase 3



Contact us


Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Nick Stone

Oncology

Kevin O'Neil

Kevin O'Neil

Rare Diseases

Christer Gruvris

BioPharmaceuticals (Cardiovascular, Renal & Metabolism), Finance

Josie Afolabi

BioPharmaceuticals (Respiratory & Immunology)

Tom Waldron

Other medicines, COVID-19

Lauren Swales

Jennifer Kretzmann

Corporate access, retail investors

US general enquiries


  • Annual reports

    Our Annual Report provides a wide range of information about our global business.


  • Our Pipeline

    Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development